# Rapport Therapeutics, Inc. (RAPP) - Q2 2026 earnings

Reported August 5, 2026.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | - | Not available |
| EPS | $-1.19 | $-1.12 |

Earnings filing reader: [8-K 0001193125-26-333853](https://www.opencapital.sh/filings/0001193125-26-333853)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001193125-26-333853.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/2012593/000119312526333853/0001193125-26-333853-index.htm)
Periodic report: 10-Q - https://www.sec.gov/Archives/edgar/data/2012593/000119312526333862/0001193125-26-333862-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/rapp/earnings/q2-2026